Steven C Gilman's Net Worth
$13.7 Million
Estimate Recalculated Apr 19, 2024 03:06PM EST
Who is Steven C Gilman?
Steven C Gilman has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include Vericel Corp, CONTRAFECT Corp, Akebia Therapeutics, Inc., SCYNEXIS INC, CUBIST PHARMACEUTICALS INC, MOMENTA PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Steven C Gilman's CIK is 0001379970
Past Insider Trading and Trends
2013 was Steven C Gilman's most active year for acquiring shares with 17 total transactions. Steven C Gilman's most active month to acquire stocks was the month of May. 2014 was Steven C Gilman's most active year for disposing of shares, totalling 26 transactions. Steven C Gilman's most active month to dispose stocks was the month of April. 2014 saw Steven C Gilman paying a total of $5,380,181.66 for 205,529 shares, this is the most they've acquired in one year. In 2015 Steven C Gilman cashed out on 309,954 shares for a total of $3,114,162.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vericel Corp (VCEL) Snapshot price: $44.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +50.00% | 2.6K |
—
|
—
| 7.8K |
Apr 27
| |||
Form 4
| -14.75% | -900.00 |
$30.94 | -$27,846.00 | 5.2K |
Scheduled
|
Apr 29
| ||
Form 4
| +74.29% | 2.6K |
—
|
—
| 6.1K |
Apr 27
| |||
Form 4
|
—
|
0
|
$21.46 | -$177,155.00 | 3.5K |
Scheduled
|
Nov 29
| ||
Form 4
|
—
|
0
|
$27.16 | -$234,170.00 | 3.5K |
Scheduled
|
Oct 27
| ||
Form 4
|
—
|
0
|
$26.30 | -$225,555.00 | 3.5K |
Scheduled
|
Sep 30
| ||
Form 4
| +100.00% | 1.75K |
—
|
—
| 3.5K |
Apr 28
| |||
Form 4
|
∞
| 1.75K |
—
|
—
| 1.75K |
Apr 29
| |||
Form 4
|
—
|
0
|
$9.79 | -$105,394.50 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$10.39 | -$114,429.00 |
0
|
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
$10.19 | -$128,553.15 |
0
|
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$7.33 | -$84,600.00 |
0
|
Scheduled
|
Sep 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONTRAFECT Corp (CFRX) Snapshot price: $0.05
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +4.00% | 800 |
$1.24 | $992.00 | 20.8K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 20K |
$2.48 | $49,600.00 | 20K |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52.51% | 30K |
—
|
—
| 87.13K |
Jun 6
| |||
Form 4
| +31.55% | 13.7K |
—
|
—
| 57.13K |
Jun 8
| |||
Form 4
| -9.52% | -4.57K |
$0.36 | -$1,653.25 | 43.43K |
Scheduled
|
Jun 3
| ||
Form 4
| -8.69% | -4.57K |
$3.32 | -$15,163.35 | 48K |
Scheduled
|
Jun 7
| ||
Form 4
| +35.25% | 13.7K |
—
|
—
| 52.56K |
Jun 2
| |||
Form 4
| +30.72% | 9.13K |
$12.08 | -$55,169.36 | 38.86K |
Scheduled
|
Jun 5 - Jun 8
| ||
Form 4
| +24.24% | 5.8K |
$3.43 | $19,894.00 | 29.73K |
Nov 20
| |||
Form 4
| +133.91% | 13.7K |
—
|
—
| 23.93K |
Jun 6
| |||
Form 4
|
∞
| 10.23K |
—
|
—
| 10.23K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCYNEXIS INC (SCYX) Snapshot price: $2.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +71.43% | 10K |
—
|
—
| 24K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +250.00% | 10K |
—
|
—
| 14K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
∞
| 4K |
$6.25 | $25,000.00 | 4K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CUBIST PHARMACEUTICALS INC No price found
EVP & Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.53K |
$102.00 | -$3,114,162.00 |
0
|
Jan 21
| |||
Form 4
| +0.30% | 82 |
$59.96 | $4,916.64 | 27.68K |
Dec 31
| |||
Form 4
|
—
|
0
|
$65.39 | $1.00 | 27.6K |
Oct 1
| |||
Form 4
|
—
|
0
|
$43.40 | -$1,476,135.44 | 27.6K |
Jul 28
| |||
Form 4
| +3.90% | 107 |
$69.82 | $7,470.74 | 2.85K |
Jun 30
| |||
Form 4
| +4.88% | 1.28K |
$42.29 | -$854,744.65 | 27.6K |
May 14 - May 15
| |||
Form 4
| +7.43% | 1.82K |
$69.00 | -$115,920.00 | 26.31K |
May 13 - May 14
| |||
Form 4
| +4.22% | 111 |
$73.15 | $8,119.65 | 2.74K |
Mar 31
| |||
Form 4
| +14.27% | 3.06K |
$75.00 | -$198,375.00 | 24.49K |
Feb 14 - Feb 18
| |||
Form 4
| -1.74% | -380.00 |
—
|
—
| 21.43K |
Jan 2
| |||
Form 4/A
| -1.36% | -1.24K |
$43.31 | -$1,223,465.47 | 89.81K |
Dec 23 - Jan 2
| |||
Form 4
| +2.12% | 489 |
$43.31 | -$1,223,465.47 | 23.54K |
Dec 27 - Jan 2
| |||
Form 4
| -2.48% | -585.00 |
—
|
—
| 23.05K |
Dec 19
| |||
Form 4
| +1.09% | 283 |
$42.49 | $12,169.15 | 26.27K |
Jun 28
| |||
Form 4
|
—
|
0
|
$35.63 | -$570,708.60 | 23.51K |
Jun 3
| |||
Form 4
| +5.85% | 1.3K |
$48.88 | -$58,699.84 | 23.51K |
May 15 - May 16
| |||
Form 4
| +7.16% | 1.48K |
$48.41 | -$49,237.75 | 22.21K |
May 14 - May 15
| |||
Form 4
| +12.88% | 2.37K |
$49.18 | -$55,818.28 | 20.73K |
May 13 - May 14
| |||
Form 4
| +60.07% | 167 |
$46.82 | $7,818.94 | 445 |
Mar 28
| |||
Form 4
| +15.89% | 2.52K |
$41.40 | -$51,046.57 | 18.36K |
Feb 15 - Feb 19
| |||
Form 4
| +0.88% | 138 |
$30.90 | -$359,823.82 | 15.84K |
Dec 31 - Jan 2
| |||
Form 4
| -3.98% | -651.00 |
—
|
—
| 15.71K |
Aug 29
| |||
Form 4
| +1.42% | 289 |
$35.07 | $10,148.51 | 20.7K |
Jun 29
| |||
Form 4
|
—
|
0
|
$30.13 | -$457,666.00 | 18.38K |
May 17
| |||
Form 4
| +22.72% | 3.4K |
$41.88 | -$66,875.36 | 18.38K |
May 14 - May 16
| |||
Form 4
| +18.75% | 2.37K |
$41.55 | -$47,162.31 | 14.98K |
May 13 - May 14
| |||
Form 4
| +1.05% | 131 |
$43.25 | $5,665.75 | 12.61K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$28.27 | -$1,486,245.87 | 12.48K |
Oct 26
| |||
Form 4
| +0.09% | 11 |
$35.32 | $388.52 | 12.48K |
Sep 30
| |||
Form 4
| +1.19% | 147 |
$35.99 | $5,290.53 | 12.47K |
Jun 30
| |||
Form 4
| +68.29% | 5K |
—
|
—
| 12.32K |
May 13 - May 15
| |||
Form 4
| +2.97% | 211 |
$25.24 | $5,325.64 | 7.32K |
Mar 31
| |||
Form 4
| +9.28% | 604 |
$17.36 | $10,483.63 | 7.11K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
| +0.71% | 46 |
$23.39 | $1,075.94 | 6.51K |
Sep 30
| |||
Form 4
| +15.40% | 862 |
$17.41 | $15,004.31 | 6.46K |
Jun 30
| |||
Form 4
| +35.44% | 1.47K |
$21.81 | -$22,576.97 | 5.6K |
May 14 - May 17
| |||
Form 4
| +5.65% | 221 |
$22.54 | $4,981.34 | 4.13K |
Mar 31
| |||
Form 4
| +10.88% | 384 |
$15.10 | $5,796.86 | 3.91K |
Dec 31
| |||
Form 4
| +2.08% | 72 |
$20.20 | $1,454.40 | 3.53K |
Sep 30
| |||
Form 4
| +22.42% | 633 |
$16.71 | $10,580.08 | 3.46K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| +11.58% | 293 |
$16.36 | $4,793.48 | 2.82K |
Mar 31
| |||
Form 4
| +7.70% | 181 |
$22.23 | $4,023.63 | 2.53K |
Sep 30
| |||
Form 4
| +10.80% | 229 |
$17.86 | $4,089.94 | 2.35K |
Jun 30
| |||
Form 4
| +6.05% | 121 |
$18.42 | $2,228.82 | 2.12K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||